Name: HCA Healthcare Inc. (NYSE:HCA) | Balance Sheet: Assets
Creator: Stock Analysis on Net

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

HCA Healthcare Inc., consolidated balance sheet: assets

US$ in millions

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash and cash equivalents	1,451)	1,793)	621)	502)	732)
Accounts receivable	8,095)	7,051)	7,380)	6,789)	6,501)
Inventories	1,986)	2,025)	1,849)	1,732)	1,573)
Other	2,010)	1,464)	1,346)	1,190)	1,171)
Current assets	13,542)	12,333)	11,196)	10,213)	9,977)
Property and equipment, net	24,063)	23,199)	22,715)	19,757)	17,895)
Investments of insurance subsidiaries	438)	388)	315)	362)	418)
Investments in and advances to affiliates	448)	422)	249)	232)	199)
Goodwill and other intangible assets	9,540)	8,578)	8,269)	7,953)	7,394)
Right-of-use operating lease assets	2,113)	2,024)	1,834)	—)	—)
Other	598)	546)	480)	690)	710)
Noncurrent assets	37,200)	35,157)	33,862)	28,994)	26,616)
Total assets	50,742)	47,490)	45,058)	39,207)	36,593)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Total assets exhibit a consistent upward trajectory, growing from US$ 36,593 million in 2017 to US$ 50,742 million by 2021. This expansion reflects a steady increase in both current and noncurrent asset bases, with a significant acceleration in growth between 2018 and 2019.

Current Asset Trends: Current assets increased from US$ 9,977 million in 2017 to US$ 13,542 million in 2021. This growth was primarily driven by accounts receivable, which rose from US$ 6,501 million to US$ 8,095 million over the period. Cash and cash equivalents experienced volatility, declining to a low of US$ 502 million in 2018 before spiking to US$ 1,793 million in 2020 and settling at US$ 1,451 million in 2021. Inventories demonstrated a gradual upward trend, peaking at US$ 2,025 million in 2020.
Noncurrent Asset Expansion: Noncurrent assets grew from US$ 26,616 million in 2017 to US$ 37,200 million in 2021. The most substantial growth is observed in property and equipment, net, which increased from US$ 17,895 million to US$ 24,063 million, indicating significant capital investment in infrastructure. Goodwill and other intangible assets also showed a steady increase, rising from US$ 7,394 million to US$ 9,540 million, suggesting a sustained strategy of growth through acquisitions.
Structural and Other Asset Changes: A structural change in the balance sheet is evident starting in 2019 with the introduction of right-of-use operating lease assets, valued at US$ 1,834 million in 2019 and increasing to US$ 2,113 million by 2021. Investments in insurance subsidiaries and advances to affiliates remained relatively small but showed a general increase toward the end of the period, with affiliates rising from US$ 199 million in 2017 to US$ 448 million in 2021.

The overall asset composition reveals a heavy reliance on fixed assets and intangibles, which together comprise the majority of the total asset value. The simultaneous growth of property and equipment and goodwill indicates a dual approach to expansion involving both organic capital expenditure and inorganic growth.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?